[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"asthma-control-level\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:asthma-control-level":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,45,67,101],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":25,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100618162","remission-in-adults-with-severe-asthma-in-thailand-100618162",false,"NCT07328035","Remission in Adults With Severe Asthma in Thailand","Inclusion Criteria:\n\n* severe asthma\n* age 18 years or older\n\nExclusion Criteria:\n\n* inability to perform spirometry or fractional exhaled nitric oxide (FeNO) test","ALL","18 Years",{"count":18,"type":19},230,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to determine the prevalence of remission among adults with severe asthma, as well as the factors associated with remission in Thailand.\n\nThe main question the study aims to answer is:\n\nWhat is the prevalence of remission among adults with severe asthma in Thailand? Participants will complete questionnaires on asthma symptoms and undergo pulmonary function testing and a blood test once.",[23,24],"Severe Asthma","Asthma Control Level",[26,27,28,29,30,31],"asthma","remission","Thailand","severe","FeNO","blood eosinophil count","RECRUITING","2026-04-16",{"date":35,"type":36},"2026-04-17","ACTUAL",{"date":38,"type":36},"2026-01-01",{"date":40,"type":19},"2026-12-31",{"name":42,"class":43},"Thammasat University","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":53,"conditions":54,"keywords":57,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":65,"locationsCount":66},"100619999","remission-in-adults-with-mild-to-moderate-asthma-in-thailand-100619999","NCT07351916","Remission in Adults With Mild-to-moderate Asthma in Thailand","Inclusion Criteria:\n\n* mild-to-moderate asthma\n* age 18 years or older\n\nExclusion Criteria:\n\n* inability to perform spirometry or fractional exhaled nitric oxide (FeNO) test",{"count":52,"type":19},289,"The goal of this observational study is to determine the prevalence of remission among adults with mild-to-moderate asthma, as well as the factors associated with remission in Thailand.\n\nThe main question the study aims to answer is:\n\nWhat is the prevalence of remission among adults with severe asthma in Thailand? Participants will complete a questionnaire on asthma symptoms and undergo pulmonary function testing and a blood test once.",[55,56,24],"Asthma","Mild-to-moderate Asthma",[26,58,59,28,27,30,31],"asthma control","mild-to-moderate asthma","2026-04-15",{"date":35,"type":36},{"date":63,"type":36},"2026-02-01",{"date":40,"type":19},{"name":42,"class":43},2,{"id":68,"slug":69,"hasResults":11,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":75,"enrollmentInfo":76,"targetDuration":4,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":85,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":44},"100605778","phase-4-45th-multicenter-airway-research-collaboration-100605778","NCT07166939","45th Multicenter Airway Research Collaboration","A Phase 4, Multicenter, Cluster Randomized, Open-label, Intervention Versus Usual Care, Controlled Study on the Effect of Emergency Department Initiation of Airsupra on Asthma Outcomes","MARC-45","INCLUSION CRITERIA:\n\n* acute asthma\n* age 18.0 to 54.9 years\n* English and\u002For Spanish speaking\n* decision by ED attending to discharge patient to home on short course of systemic corticosteroids\n* (intervention group only) Willingness to use Airsupra as their rescue inhaler for next 3 months\n* demonstration of acceptable MDI administration technique\n* provision of informed consent prior to any study-specific procedures\n\nEXCLUSION CRITERIA:\n\n* involvement in the planning and\u002For conduct of the study\n* previous enrolment in the present study\n* prior diagnosis of COPD, chronic bronchitis, or emphysema\n* use of systemic corticosteroids in the past 2 weeks\n* participation in another clinical study with an investigational product during the past 4 weeks or the 3 months after enrollment in the current study\n* concurrent pneumonia\n* clinically significant cardiovascular disease or clinically significant cancer\n* patients with known hypersensitivity to Airsupra, albuterol sulfate, budesonide, or any of the excipients of the product\n* (for women only, by self-report):\n* currently pregnant\n* currently breastfeeding,\n* (among sexually active women of child-bearing age only) not using adequate contraception over the last 3 months, or no plan to use adequate contraception over the next 3 months\n* lack of a working cell phone and working email address\n* expected lack of availability for text and\u002For telephone follow-up at approximately 3, 6, and 12 weeks after the ED visit\n* inability to provide an alternate contact with a working cell phone and working email address.","54 Years",{"count":77,"type":19},1860,"INTERVENTIONAL",[80],"PHASE4","The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma \"recurrence\" at 3 months and other related outcomes (acute asthma relapse, asthma control).",[83,84,55,24],"Asthma Acute","Asthma Exacerbation",[26,86,87,88,89,90,58,91,92],"emergency department","airsupra","randomized trial","acute asthma recurrence","acute asthma relapse","acute asthma","asthma exacerbation","2026-04-14",{"date":35,"type":36},{"date":96,"type":36},"2025-11-07",{"date":98,"type":19},"2027-06",{"name":100,"class":43},"Massachusetts General Hospital",{"id":102,"slug":103,"hasResults":11,"nctId":104,"briefTitle":105,"officialTitle":106,"acronym":4,"eligibilityCriteria":107,"healthyVolunteers":11,"sex":15,"minAge":108,"maxAge":109,"enrollmentInfo":110,"targetDuration":4,"studyType":78,"phases":112,"briefSummary":114,"conditions":115,"keywords":120,"overallStatus":124,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":44},"100594912","effects-of-buteyko-breathing-exercise-in-children-with-uncontrolled-asthma-100594912","NCT07025616","Effects of Buteyko Breathing Exercise in Children With Uncontrolled Asthma","Effectiveness of Buteyko Breathing Exercise in Children With Uncontrolled Asthma: A Single Blind, Randomized Controlled Trial","Inclusion Criteria:\n\n1. Children aged 7-17 years\n2. Uncontrolled or partially controlled asthma (GINA Symptom Control Tool score \\> 1)\n3. Receive bronchodilator therapy, either oral or inhaler from a pediatrician.\n4. Children and parents\u002Fcare givers agree to participate in the study until the end, and parents\u002Fcare givers sign the informed consent form.\n5. Can understand instructions.\n\nExclusion Criteria:\n\n1. Inpatients\n2. Have received Buteyko breathing exercises or other breathing exercises.\n3. Have congenital heart disease, pneumonia, or other significant and uncontrolled health disorders.\n4. Have severe physical disabilities or mental retardation that could potentially prevent the implementation of Buteyko breathing exercises.\n5. Have contraindications for spirometry examination","7 Years","17 Years",{"count":111,"type":19},74,[113],"NA","This randomized controlled trial study aimed to measure the effectiveness of the combination of 4-weeks Buteyko breathing exercises and pharmacological therapy compared with pharmacological therapy alone in children with uncontrolled asthma.",[116,24,117,118,119],"Breathing Techniques","Asthma in Children","Asthma Patients","Breathing Exercise",[55,121,122,123],"Buteyko","breathing retraining","pediatrics","NOT_YET_RECRUITING","2025-06-13",{"date":127,"type":36},"2025-06-17",{"date":129,"type":19},"2025-06",{"date":131,"type":19},"2025-12",{"name":133,"class":43},"Ivan Sofian Wibowo"]